|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Desantis C and Jemal A:
Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:104–117.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Zuo T, Zeng H, Zhang S
and He J: National cancer incidence and mortality in China, 2012.
Chin J Cancer Res. 28:1–11. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Weir B, Zhao X and Meyerson M: Somatic
alterations in the human cancer genome. Cancer Cell. 6:433–438.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang B, Balakrishnan-Renuka A, Napirei M,
Theiss C and Brand-Saberi B: Spatiotemporal expression of Math6
during mouse embryonic development. Histochem Cell Biol.
143:575–582. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Inoue C, Bae SK, Takatsuka K, Inoue T,
Bessho Y and Kageyama R: Math6, a bHLH gene expressed in the
developing nervous system, regulates neuronal versus glial
differentiation. Genes Cells. 6:977–986. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lynn FC, Sanchez L, Gomis R, German MS and
Gasa R: Identification of the bHLH factor Math6 as a novel
component of the embryonic pancreas transcriptional network. PLoS
One. 3:e24302008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ross MD, Martinka S, Mukherjee A, Sedor
JR, Vinson C and Bruggeman LA: Math6 expression during kidney
development and altered expression in a mouse model of
glomerulosclerosis. Dev Dyn. 235:3102–3109. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fang F, Wasserman SM, Torres-Vazquez J,
Weinstein B, Cao F, Li Z, Wilson KD, Yue W, Wu JC, Xie X, et al:
The role of Hath6, a newly identified shear-stress-responsive
transcription factor, in endothelial cell differentiation and
function. J Cell Sci. 127:1428–1440. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Güttsches AK, Balakrishnan-Renuka A, Kley
RA, Tegenthoff M, Brand-Saberi B and Vorgerd M: ATOH8: A novel
marker in human muscle fiber regeneration. Histochem Cell Biol.
143:443–452. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yao J, Zhou J, Liu Q, Lu D, Wang L, Qiao X
and Jia W: Atoh8, a bHLH transcription factor, is required for the
development of retina and skeletal muscle in zebrafish. PLoS One.
5:e109452010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Song Y, Pan G, Chen L, Ma S, Zeng T, Chan
Man TH, Li L, Lian Q, Chow R, Cai X, et al: Loss of ATOH8 increases
stem cell features of hepatocellular carcinoma cells.
Gastroenterology. 149:1068–1081.e5. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Z, Xie J, Yan M, Wang J, Wang X,
Zhang J, Zhang Y, Li P, Lei X, Huang Q, et al: Downregulation of
ATOH8 induced by EBV-encoded LMP1 contributes to the malignant
phenotype of nasopharyngeal carcinoma. Oncotarget. 7:26765–26779.
2016.PubMed/NCBI
|
|
14
|
Zaravinos A, Lambrou GI, Boulalas I,
Delakas D and Spandidos DA: Identification of common differentially
expressed genes in urinary bladder cancer. PLoS One. 6:e181352011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Freire P, Vilela M, Deus H, Kim YW, Koul
D, Colman H, Aldape KD, Bogler O, Yung WK, Coombes K, et al:
Exploratory analysis of the copy number alterations in glioblastoma
multiforme. PLoS One. 3:e40762008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hazelett DJ, Rhie SK, Gaddis M, Yan C,
Lakeland DL, Coetzee SG, Henderson BE, Noushmehr H, Cozen W,
Kote-Jarai Z, et al: Ellipse/GAME-ON consortium; Practical
consortium: Comprehensive functional annotation of 77 prostate
cancer risk loci. PLoS Genet. 10:e10041022014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chang A, Chen Y, Shen W, Gao R, Zhou W,
Luo Y, Luo N, Stupack D and Xiang R: Abstract 1956: The basic
helix-loop-helix (bHLH) transcriptional factor ATOH8 promotes the
stemness of breast cancer cells via Oct4 and Nanog. Cancer Res.
74:(Suppl 19): Abstract nr 1956.
2014.doi:10.1158/1538-7445.AM2014-1956.
|
|
18
|
Chu X, Zhao P, Lv Y and Liu L: Decreased
expression of TFPI-2 correlated with increased expression of CD133
in cholangiocarcinoma. Int J Clin Exp Pathol. 8:328–336.
2015.PubMed/NCBI
|
|
19
|
Ejarque M, Mir-Coll J, Gomis R, German MS,
Lynn FC and Gasa R: Generation of a conditional allele of the
transcription factor atonal homolog 8 (Atoh8). PLoS One.
11:e01462732016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Balakrishnan-Renuka A, Morosan-Puopolo G,
Yusuf F, Abduelmula A, Chen J, Zoidl G, Philippi S, Dai F and
Brand-Saberi B: ATOH8, a regulator of skeletal myogenesis in the
hypaxial myotome of the trunk. Histochem Cell Biol. 141:289–300.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bowden NA, Croft A and Scott RJ: Gene
expression profiling in familial adenomatous polyposis adenomas and
desmoid disease. Hered Cancer Clin Pract. 5:79–96. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tampellini M, Ottone A, Alabiso I,
Baratelli C, Forti L, Berruti A, Aroasio E and Scagliotti GV: The
prognostic role of baseline CEA and CA 19–9 values and their
time-dependent variations in advanced colorectal cancer patients
submitted to first-line therapy. Tumor Biol. 36:1519–1527. 2015.
View Article : Google Scholar
|
|
23
|
Yang KL, Yang SH, Liang WY, Kuo YJ, Lin
JK, Lin TC, Chen WS, Jiang JK, Wang HS, Chang SC, et al:
Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment
outcome of rectal cancer patients receiving pre-operative
chemoradiation and surgery. Radiat Oncol. 8:432013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen L, Jiang B, Di J, Zhang C, Wang Z,
Zhang N, Xing J, Cui M, Yang H, Yao Z, et al: Predictive value of
preoperative detection of CEA and CA199 for prognosis in patients
with stage II–III colorectal cancer. Zhonghua Wei Chang Wai Ke Za
Zhi. 18:914–919. 2015.(In Chinese). PubMed/NCBI
|
|
25
|
Tsigelny IF, Kouznetsova VL, Pingle SC and
Kesari S: bHLH Transcription factors inhibitors for cancer therapy:
General features for in silico drug design. Curr Med Chem.
21:3227–3243. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhu R, Yang Y, Tian Y, Bai J, Zhang X, Li
X, Peng Z, He Y, Chen L, Pan Q, et al: Ascl2 knockdown results in
tumor growth arrest by miRNA-302b-related inhibition of colon
cancer progenitor cells. PLoS One. 7:e321702012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Patel D and Chaudhary J: Increased
expression of bHLH transcription factor E2A (TCF3) in prostate
cancer promotes proliferation and confers resistance to doxorubicin
induced apoptosis. Biochem Biophys Res Commun. 422:146–151. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Axelson H: The Notch signaling cascade in
neuroblastoma: Role of the basic helix-loop-helix proteins HASH-1
and HES-1. Cancer Lett. 204:171–178. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sang L, Roberts JM and Coller HA:
Hijacking HES1: How tumors co-opt the anti-differentiation
strategies of quiescent cells. Trends Mol Med. 16:17–26. 2010.
View Article : Google Scholar : PubMed/NCBI
|
